Ozone oxidative postconditioning ameliorates joint damage and decreases pro-inflammatory cytokine levels and oxidative stress in PG/PS-induced arthritis in rats

European Journal of Pharmacology

Volumn 714, Issue 1-3, 2013, Pages 318-324

  Vaillant, Jaqueline Dranguet ^a   Fraga, Angela ^a   Díaz, María Teresa ^a   Mallok, A ^a   Viebahn Hänsler, Renate ^b   Fahmy, Ziad ^b   Barberá, Ariana ^c   Delgado, Liván ^a   Menéndez, Silvia ^d   Fernández, Olga Sonia León ^a  

^a UNIVERSITY OF HAVANA   (Cuba)

^b Medical Society for the Use of Ozone in Prevention and Therapy   (Germany)

^c CENTER FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Cuba)

^d Centro ProDanza   (Cuba)

Author keywords

Arthritis; Inflammation; Oxidative stress; Ozone oxidative postconditioning

Indexed keywords

FRUCTOLYSINE; INTERLEUKIN 1BETA; LYSINE DERIVATIVE; MESSENGER RNA; NITRIC OXIDE; OZONE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTHRITIS; ARTICLE; CONTROLLED STUDY; FEMALE; JOINT INJURY; NONHUMAN; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; OXYGEN THERAPY; OZONE OXIDATIVE POSTCONDITIONING; PRIORITY JOURNAL; RAT; SPLEEN; THERAPY EFFECT; TISSUE HOMOGENATE;

ARTHRITIS; INFLAMMATION; OXIDATIVE STRESS; OZONE OXIDATIVE POSTCONDITIONING;

ANIMALS; ARTHRITIS, RHEUMATOID; CYTOKINES; FEMALE; INFLAMMATION; JOINTS; OXIDATION-REDUCTION; OXIDATIVE STRESS; OZONE; PEPTIDOGLYCAN; POLYSACCHARIDES; RATS;

EID: 84885434841     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2013.07.034     Document Type: Article

References (31)

1. Ajamieh, H.H., Menendez, S., Martinez-Sanchez, G., Candelario-Jalil, E., Re, L., Giuliani, A., Fernandez, O.S., 2004. Effects of ozone oxidative preconditioning on nitric oxide generation and cellular redox balance in a rat model of hepatic ischaemia-reperfusion. Liver International 24, 55-62. (Pubitemid 38351214)
2. Alivernini, S., Fedele, A.L., Cuoghi, I., Tolusso, B., Ferraccioli, G., 2008. Citrullination: the loss of tolerance and development of autoimmunity in rheumatoid arthritis. Reumatismo 60, 85-94.
3. Atassi, M.Z., Casali, P., 2008. Molecular mechanisms of autoimmunity. Autoimmu-nity 41, 123-132. (Pubitemid 351372294)
4. Biniecka, M., Kennedy, A., Ng, C.T., Chang, T.C., Balogh, E., Fox, E., Veale, D.J., Fearon, U., O'Sullivan, J.N., 2011. Successful tumour necrosis factor (TNF) blocking therapy suppresses oxidative stress and hypoxia-induced mitochondrial mutagenesis in inflammatory arthritis. Arthritis Research and Therapy 13, R121.
5. Boehringer-Mannheim, 1987. Biochemica Information. A Revised Biochemical Reference Source. Enzymes for Routine, 1st ed. Boehringer Mannheim, Berlin, pp. 80-81.
6. Connor, J.R., Manning, P.T., Settle, S.L., Moore, W.M., Jerome, G.M., Webber, R.K., Tjoeng, F.S., Currie, M.G., 1995. Suppression of adjuvant-induced arthritis by selective inhibition of inducible nitric oxide synthase. European Journal of Pharmacology 273, 15-24.
7. Doyle, H.A., Mamula, M.J., 2005. Posttranslational modifications of self-antigens. Annals of the New York Academy of Sciences 1050, 1-9. (Pubitemid 41129418)
8. Gaston, J.S., 1995. The involvement of the gut in the pathogenesis of inflammatory synovitis. British Journal of Rheumatology 34, 801-802.
9. Gelderman, K.A., Hultqvist, M., Olsson, L.M., Bauer, K., Pizzolla, A., Olofsson, P., Holmdahl, R., 2007. Rheumatoid arthritis: the role of reactive oxygen species in disease development and therapeutic strategies. Antioxidants and Redox Signaling 9, 1541-1567. (Pubitemid 47462961)
10. Gonzalez-Gay, M.A., Llorca, J., Sanchez, E., Lopez-Nevot, M.A., Amoli, M.M., Garcia-Porrua, C., Ollier, W.E., Martin, J., 2004. Inducible but not endothelial nitric oxide synthase polymorphism is associated with susceptibility to rheumatoid arthritis in northwest Spain. Rheumatology 43, 1182-1185. (Pubitemid 39232826)
11. Granger, D.L., Taintor, R.R., Boockvar, K.S., Hibbs, J.B., 1995. Determination of nitrate and nitrite in biological samples using bacterial nitrate reductase coupled with the griess reaction. Methods 7, 78-83.
12. Karouzakis, E., Neidhart, M., Gay, R.E., Gay, S., 2006. Molecular and cellular basis of rheumatoid joint destruction. Immunology Letters 106, 8-13. (Pubitemid 44093056)
13. Kimpel, D., Dayton, T., Fuseler, J., Gray, L., Kannan, K., Wolf, R.E., Grisham, M., 2003. Splenectomy attenuates streptococcal cell wall-induced arthritis and alters leukocyte activation. Arthritis and Rheumatism 48, 3557-3567. (Pubitemid 37531924)
14. Klareskog, L., Stolt, P., Lundberg, K., Kallberg, H., Bengtsson, C., Grunewald, J., Ronnelid, J., Harris, H.E., Ulfgren, A.K., Rantapaa-Dahlqvist, S., Eklund, A., Padyukov, L., Alfredsson, L., 2006. A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis and Rheumatism 54, 38-46. (Pubitemid 43122184)
15. Leon Fernandez, O.S., Ajamieh, H.H., Berlanga, J., Menendez, S., Viebahn-Hansler, R., Re, L., Carmona, A.M., 2008. Ozone oxidative preconditioning is mediated by A1 adenosine receptors in a rat model of liver ischemia/reperfusion. Transplant International 21, 39-48. (Pubitemid 350198290)
16. Leon, O.S., Menendez, S., Merino, N., Castillo, R., Sam, S., Perez, L., Cruz, E., Bocci, V., 1998. Ozone oxidative preconditioning: a protection against cellular damage by free radicals. Mediators of Inflammation 7, 289-294. (Pubitemid 28419524)
17. Mabley, J.G., Liaudet, L., Pacher, P., Southan, G.J., Groves, J.T., Salzman, A.L., Szabo, C., 2002. Part II: beneficial effects of the peroxynitrite decomposition catalyst FP15 in murine models of arthritis and colitis. Molecular Medicine 8, 581-590. (Pubitemid 36337503)
18. Miyata, T., Ishiguro, N., Yasuda, Y., Ito, T., Nangaku, M., Iwata, H., Kurokawa, K., 1998. Increased pentosidine, an advanced glycation end product, in plasma and synovial fluid from patients with rheumatoid arthritis and its relation with inflammatory markers. Biochemical and Biophysical Research Communications 244, 45-49. (Pubitemid 28419898)
19. Nagy, G., Clark, J.M., Buzas, E., Gorman, C., Pasztoi, M., Koncz, A., Falus, A., Cope, A.P., 2008. Nitric oxide production of T lymphocytes is increased in rheumatoid arthritis. Immunology Letters 118, 55-58.
20. Nagy, G., Clark, J.M., Buzas, E.I., Gorman, C.L., Cope, A.P., 2007. Nitric oxide, chronic inflammation and autoimmunity. Immunology Letters 111, 1-5. (Pubitemid 47017476)
21. Pacher, P., Beckman, J.S., Liaudet, L., 2007. Nitric oxide and peroxynitrite in health and disease. Physiological Reviews 87, 315-424. (Pubitemid 46217686)
22. Pham, T.N., Rahman, P., Tobin, Y.M., Khraishi, M.M., Hamilton, S.F., Alderdice, C., Richardson, V.J., 2003. Elevated serum nitric oxide levels in patients with inflammatory arthritis associated with co-expression of inducible nitric oxide synthase and protein kinase C-eta in peripheral blood monocyte-derived macrophages. Journal of Rheumatology 30, 2529-2534. (Pubitemid 37549325)
23. Sakurai, H., Kohsaka, H., Liu, M.F., Higashiyama, H., Hirata, Y., Kanno, K., Saito, I., Miyasaka, N., 1995. Nitric oxide production and inducible nitric oxide synthase expression in inflammatory arthritides. Journal of Clinical Investigation 96, 2357-2363.
24. Salvemini, D., Mazzon, E., Dugo, L., Serraino, I., De Sarro, A., Caputi, A.P., Cuzzocrea, S., 2001. Amelioration of joint disease in a rat model of collagen-induced arthritis by M40403, a superoxide dismutase mimetic. Arthritis and Rheumatism 44, 2909-2921. (Pubitemid 34016211)
25. Sandhu, J.K., Robertson, S., Birnboim, H.C., Goldstein, R., 2003. Distribution of protein nitrotyrosine in synovial tissues of patients with rheumatoid arthritis and osteoarthritis. Journal of Rheumatology 30, 1173-1181. (Pubitemid 36666337)
26. Symmons, D., Turner, G., Webb, R., Asten, P., Barrett, E., Lunt, M., Scott, D., Silman, A., 2002. The prevalence of rheumatoid arthritis in the United Kingdom: new estimates for a new century. Rheumatology 41, 793-800. (Pubitemid 34822963)
27. Thome, J., Munch, G., Muller, R., Schinzel, R., Kornhuber, J., Blum-Degen, D., Sitzmann, L., Rosler, M., Heidland, A., Riederer, P., 1996. Advanced glycation endproducts-associated parameters in the peripheral blood of patients with Alzheimer's disease. Life Sciences 59, 679-685. (Pubitemid 26274409)
28. van't Hof, R.J., Armour, K.J., Smith, L.M., Armour, K.E., Wei, X.Q., Liew, F.Y., Ralston, S.H., 2000. Requirement of the inducible nitric oxide synthase pathway for IL-1-induced osteoclastic bone resorption. Proceedings of the National Academy of Sciences of the United States of America 97, 7993-7998. (Pubitemid 30460761)
29. van Venrooij, W.J., Pruijn, G.J., 2000. Citrullination: a small change for a protein with great consequences for rheumatoid arthritis. Arthritis Research 2, 249-251. (Pubitemid 32223741)
30. Vytasek, R., Sedova, L., Vilim, V., 2010. Increased concentration of two different advanced glycation end-products detected by enzyme immunoassays with new monoclonal antibodies in sera of patients with rheumatoid arthritis. BMC Musculoskeletal Disorders 11, 83.
31. Woo, C.H., Eom, Y.W., Yoo, M.H., You, H.J., Han, H.J., Song, W.K., Yoo, Y.J., Chun, J.S., Kim, J.H., 2000. Tumor necrosis factor-alpha generates reactive oxygen species via a cytosolic phospholipase A2-linked cascade. Journal of Biological Chemistry 275, 32357-32362.